Clinical Trial Update: A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

View source ↗

Summary

Clinical trial update on the bortezomib, lenalidomide, and dexamethasone regimen for newly diagnosed multiple myeloma, with the study status listed as completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Myeloma | Status: COMPLETED